Regenerative medicine startup to buy key assets of Peninsula company


PACT Pharma plans to ask the Food and Drug Administration next year to approve its off-the-shelf cancer cell therapy, and AmplifyBio expects to expand its new presence in South San Francisco.

Previous 3 reasons why Virta Health is moving its HQ from San Francisco to Denver, according to the CEO
Next 'Significantly' undervalued $1 billion offer for Peninsula biopharma sends stock soaring